Literature DB >> 21543926

Vascular endothelial growth factor gene polymorphisms and risk of cervical intraepithelial neoplasia.

Christoph Grimm1, Rafal Watrowski, Stephan Polterauer, Konstantin Baumühlner, Camilla Natter, Jasmin Rahhal, Georg Heinze, Eva Schuster, Lukas Hefler, Alexander Reinthaller.   

Abstract

OBJECTIVE: To evaluate the association between 3 vascular endothelial growth factor (VEGF) gene polymorphisms and susceptibility of cervical intraepithelial neoplasia (CIN).
MATERIALS AND METHODS: This prospectively collected case-control study investigates three common VEGF gene polymorphisms (ie, VEGF -460 [rs833061], VEGF +405 [rs2010963], and VEGF +936 [rs3025039]) in 203 women with CIN and 209 healthy women by DNA pyrosequencing. Associations between polymorphisms and CIN risk are evaluated with univariate and multivariable models and haplotype analysis.
RESULTS: In a multivariable regression model, the variant VEGF +405C allele was associated (odds ratio [OR], 2.5; 95% confidence interval [CI], 1.2-5.1], P = 0.02) with increased susceptibility of CIN independent of number of sexual partners (OR, 2.2; 95% CI, 1.1-4.6; P = 0.03) and smoking (OR, 3.3; 95% CI, 1.6-6.6; P = 0.001). The haplotype VEGF -460C - +405C - +936C was associated with an OR of 5.2 (95% CI, 1.2-52.7) for the susceptibility of CIN.
CONCLUSIONS: The presence of the variant VEGF +405C allele and the haplotype VEGF -460C - +405C - +936C are independently associated with higher susceptibility of CIN.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21543926     DOI: 10.1097/IGC.0b013e318214557c

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  6 in total

1.  [Medical University of Vienna Researcher of the Month of March 2013].

Authors:  Christoph Grimm
Journal:  Wien Klin Wochenschr       Date:  2013-03       Impact factor: 1.704

Review 2.  Polymorphisms of vascular endothelial growth factor and recurrent implantation failure: a systematic review and meta-analysis.

Authors:  Hong Zeng; Lian Hu; Hebin Xie; Wenmin Ma; Song Quan
Journal:  Arch Gynecol Obstet       Date:  2021-04-23       Impact factor: 2.344

3.  Clinical Relevance of VEGFA (rs3025039) +936 C>T Polymorphism in Primary Myelofibrosis: Susceptibility, Clinical Co-Variates, and Outcomes.

Authors:  Laura Villani; Adriana Carolei; Vittorio Rosti; Margherita Massa; Rita Campanelli; Paolo Catarsi; Carlotta Abbà; Robert Peter Gale; Giovanni Barosi
Journal:  Genes (Basel)       Date:  2021-08-20       Impact factor: 4.096

4.  Association of traffic-related hazardous air pollutants and cervical dysplasia in an urban multiethnic population: a cross-sectional study.

Authors:  Michael E Scheurer; Heather E Danysh; Michele Follen; Philip J Lupo
Journal:  Environ Health       Date:  2014-06-13       Impact factor: 5.984

5.  Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Rossana Berardi; Mariangela Torniai; Stefano Partelli; Corrado Rubini; Silvia Pagliaretta; Agnese Savini; Vanessa Polenta; Matteo Santoni; Riccardo Giampieri; Sofia Onorati; Federica Barucca; Alberto Murrone; Francesca Bianchi; Massimo Falconi
Journal:  PLoS One       Date:  2018-05-22       Impact factor: 3.240

6.  Clinical Relevance of +936 C>T VEGFA and c.233C>T bFGF Polymorphisms in Chronic Lymphocytic Leukemia.

Authors:  Sandra Ballester; Begoña Pineda; Patricia Rodrigues; Eduardo Tormo; María José Terol; Pilar Eroles
Journal:  Genes (Basel)       Date:  2020-06-23       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.